American Cyanamid Company

Jeffrey B Medwid

Lawrence W Torley

Andrew S Tomcufcik

This disclosure describes certain substituted piperazine-1,4-naphthalenediones useful as anti-asthmatic agents.

Substituted piperazine-1,4-naphthalenediones useful as anti-asthmatic

This disclosure describes novel substituted 2-phenyl-1H-benzimidazoles and 2-phenyl-1H-benzimidazole-4,7-diones and novel 5-chloro-6-(4-substituted-1-piperazinyl)-2,1,3-benzothiadiazole-4,7-diones ; all of which are highly active as anti-asthmatic and anti-allergic agents.

Substituted benzimidazoles and benzothidiazoles having anti-asthmatic

Substituted piperazine-1,4-naphthalenediones useful for treating asthma,

This disclosure describes novel 6-(4-substituted-1-piperazinyl)-5,8-quinolinediones, 7-(4-substituted-1-piperazinyl)-5,8-quinolinediones, and 6-(4-substituted-1-piperazinyl)-5,8-quinoxalinediones which possess activity as anti-asthmatic and anti-allergic agents.

Substituted quinoxalinediones and their methods of use

This disclosure describes novel 6-(4-substituted-1-piperazinyl)-5,8-quinolinediones, 7-(4-substituted-1-piperazinyl)-5,8-quinolinediones, and 6-(4-substituted-1-piperazinyl)-5,8-quinoxalinediones which possess activity an anti-asthmatic and anti-allergic agents.

Growing community of inventors

West Nyack, NY, United States of America

Jeffrey B Medwid